Quince Therapeutics
Price & Volume
Stats
See moreOpen | $33.50 |
Previous Close | $32.50 |
Day Range | $33.20-$35.17 |
52W Range | $15.10-$910 |
Market Cap | $33M |
Shares Short | 60,277 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$210.84 |
News
See moreYahoo Finance • last month
Top Biotech Gainers: NXTC Soars On Merger Deal, BMGL Moves Past Nasdaq Woes, OTLK Awaits FDA Verdict
Yahoo Finance • 3 months ago
Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline
Yahoo Finance • 3 months ago
Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
Yahoo Finance • 6 months ago
BC-Most Active Stocks
About
CEO | Dr. Dirk Thye M.D. |
Address | 611 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 38 |